Rankings
▼
Calendar
FENC FY 2024 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
FENC
Fennec Pharmaceuticals Inc.
$220M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$48M
+123.7% YoY
Gross Profit
$44M
93.3% margin
Operating Income
$3M
5.4% margin
Net Income
-$436,000
-0.9% margin
EPS (Diluted)
$-0.02
Cash Flow
Operating Cash Flow
$27M
Free Cash Flow
$27M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$45M
Total Liabilities
$51M
Stockholders' Equity
-$6M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$48M
$21M
+123.7%
Gross Profit
$44M
$20M
+121.8%
Operating Income
$3M
-$13M
+120.1%
Net Income
-$436,000
-$16M
+97.3%
← Q4 2023
All Quarters
Q1 2024 →